Tenax Therapeutics Inc. Company Profile
NASDAQ: TENXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:13 PM ET
Tenax Therapeutics at a glance
Tenax Therapeutics Inc. (NASDAQ: TENX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Chapel Hill, NC. Tenax Therapeutics is led by Mr. Christopher T. Giordano and employs about 14 people. At a market capitalization of $69.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0000034956, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Tenax Therapeutics do?
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Business description based on the company's public filings.
Company information
- Legal name
- Tenax Therapeutics Inc.
- Ticker
- NASDAQ: TENX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Christopher T. Giordano
- Employees
- 14
- Headquarters
- 101 Glen Lennox Drive, Chapel Hill, NC, United States
- Phone
- 919 855 2100
- Website
- tenaxthera.com
- Market cap
- $69.61M
- SEC CIK
- 0000034956
- Latest annual report
- 10-K · Mar 10, 2026
Companies similar to Tenax Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HYFTMindWalk Holdings Corp. | 1.49 | +4.22% | $70.20M | vs TENX |
| SPROSpero Therapeutics Inc. | 1.21 | +5.75% | $70.22M | vs TENX |
| CINGCingulate Inc. | 4.89 | +0.25% | $71.14M | vs TENX |
| GANXGain Therapeutics Inc. | 1.63 | +0.93% | $71.14M | vs TENX |
| FBIOFortress Biotech Inc. | 2.13 | +2.11% | $71.17M | vs TENX |
| RNTXRein Therapeutics Inc. | 0.7867 | +2.26% | $67.87M | vs TENX |
| XBITXBiotech Inc. | 2.22 | +0.91% | $67.68M | vs TENX |
| ONCYOncolytics Biotech Inc. | 0.5519 | +1.38% | $72.37M | vs TENX |